Peripheral Intervention Drug-Eluting Devices Market Report

Europe Peripheral Intervention Drug-Eluting Devices Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 29, 2020
  • PAGES：144
  • REPORT CODE：GMM452651
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Peripheral Intervention Drug-Eluting Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Peripheral Intervention Drug-Eluting Devices Market Segmentations:

    By Player:

    • Medtronic plc

    • Abbott Laboratories

    • Boston Scientific Corporation

    • Terumo Corporation

    • Cardinal Health

    • The Lubrizol Corporation

    By Type:

    • Plain Old Balloon Angioplasty (POBA)

    • Percutaneous Transluminal Angioplasty (PTA)

    By End-User:

    • Drug-Eluting Balloons

    • Drug-Eluting Stents

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Peripheral Intervention Drug-Eluting Devices Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Plain Old Balloon Angioplasty (POBA) from 2014 to 2026

    • 1.3.2 Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Percutaneous Transluminal Angioplasty (PTA) from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Drug-Eluting Balloons from 2014 to 2026

    • 1.4.2 Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Drug-Eluting Stents from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Peripheral Intervention Drug-Eluting Devices Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Peripheral Intervention Drug-Eluting Devices by Major Types

      • 3.4.1 Market Size and Growth Rate of Plain Old Balloon Angioplasty (POBA)

      • 3.4.2 Market Size and Growth Rate of Percutaneous Transluminal Angioplasty (PTA)

    4 Segmentation of Peripheral Intervention Drug-Eluting Devices Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Peripheral Intervention Drug-Eluting Devices by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Peripheral Intervention Drug-Eluting Devices for Drug-Eluting Balloons

      • 4.4.2 Market Size and Growth Rate of Peripheral Intervention Drug-Eluting Devices for Drug-Eluting Stents

    5 Market Analysis by Major Regions

    • 5.1 Europe Peripheral Intervention Drug-Eluting Devices Production Analysis by Top Regions

    • 5.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption Analysis by Top Regions

    • 5.3 Europe Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.3 France Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    6 Product Circulation of Peripheral Intervention Drug-Eluting Devices Market among Top Countries

    • 6.1 Top 5 Export Countries in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 7.1 Germany Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 7.2 Germany Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    8. UK Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 8.1 UK Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 8.2 UK Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    9. France Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 9.1 France Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 9.2 France Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    10. Italy Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 10.1 Italy Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 10.2 Italy Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    11. Spain Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 11.1 Spain Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 11.2 Spain Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    12. Poland Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 12.1 Poland Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 12.2 Poland Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    13. Russia Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 13.1 Russia Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 13.2 Russia Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    14. Switzerland Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 14.1 Switzerland Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 14.2 Switzerland Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    15. Turkey Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 15.1 Turkey Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 15.2 Turkey Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Top Countries

      • 16.3.1 Denmark Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 16.3.2 Finland Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 16.3.3 Norway Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 16.3.4 Sweden Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 16.3.6 Iceland Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Top Countries

      • 17.3.1 Belgium Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 17.3.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 17.3.3 Luxembourg Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Landscape Analysis by Top Countries

      • 18.3.1 Estonia Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 18.3.2 Latvia Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

      • 18.3.3 Lithuania Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Medtronic plc

      • 19.1.1 Medtronic plc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Abbott Laboratories

      • 19.2.1 Abbott Laboratories Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Boston Scientific Corporation

      • 19.3.1 Boston Scientific Corporation Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Terumo Corporation

      • 19.4.1 Terumo Corporation Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Cardinal Health

      • 19.5.1 Cardinal Health Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 The Lubrizol Corporation

      • 19.6.1 The Lubrizol Corporation Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 70 Figures and 135 Tables)

    • Figure Product Picture

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Plain Old Balloon Angioplasty (POBA) from 2014 to 2026

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Percutaneous Transluminal Angioplasty (PTA) from 2014 to 2026

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Drug-Eluting Balloons from 2014 to 2026

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Drug-Eluting Stents from 2014 to 2026

    • Figure Germany Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure UK Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure France Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Peripheral Intervention Drug-Eluting Devices Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Peripheral Intervention Drug-Eluting Devices

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Peripheral Intervention Drug-Eluting Devices by Different Types from 2014 to 2026

    • Table Consumption Share of Peripheral Intervention Drug-Eluting Devices by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Plain Old Balloon Angioplasty (POBA)

    • Figure Market Size and Growth Rate of Percutaneous Transluminal Angioplasty (PTA)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Peripheral Intervention Drug-Eluting Devices by Different End-Users from 2014 to 2026

    • Table Consumption Share of Peripheral Intervention Drug-Eluting Devices by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Drug-Eluting Balloons

    • Figure Market Size and Growth Rate of Drug-Eluting Stents

    • Table Europe Peripheral Intervention Drug-Eluting Devices Production by Major Regions

    • Table Europe Peripheral Intervention Drug-Eluting Devices Production Share by Major Regions

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Production Share by Major Countries and Regions in 2014

    • Table Europe Peripheral Intervention Drug-Eluting Devices Consumption by Major Regions

    • Table Europe Peripheral Intervention Drug-Eluting Devices Consumption Share by Major Regions

    • Table Germany Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table UK Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table France Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Italy Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Spain Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Poland Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Russia Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Switzerland Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Turkey Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Peripheral Intervention Drug-Eluting Devices Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Germany Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Germany Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Germany Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table UK Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table UK Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table UK Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table UK Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table France Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table France Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table France Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table France Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Italy Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Italy Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Italy Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Italy Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Spain Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Spain Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Spain Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Spain Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Poland Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Poland Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Poland Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Poland Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Russia Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Russia Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Russia Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Russia Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Switzerland Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Switzerland Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Switzerland Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Turkey Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Turkey Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Turkey Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peripheral Intervention Drug-Eluting Devices Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peripheral Intervention Drug-Eluting Devices Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peripheral Intervention Drug-Eluting Devices Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Peripheral Intervention Drug-Eluting Devices Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Medtronic plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic plc

    • Figure Sales and Growth Rate Analysis of Medtronic plc

    • Figure Revenue and Market Share Analysis of Medtronic plc

    • Table Product and Service Introduction of Medtronic plc

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Boston Scientific Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Scientific Corporation

    • Figure Sales and Growth Rate Analysis of Boston Scientific Corporation

    • Figure Revenue and Market Share Analysis of Boston Scientific Corporation

    • Table Product and Service Introduction of Boston Scientific Corporation

    • Table Company Profile and Development Status of Terumo Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Terumo Corporation

    • Figure Sales and Growth Rate Analysis of Terumo Corporation

    • Figure Revenue and Market Share Analysis of Terumo Corporation

    • Table Product and Service Introduction of Terumo Corporation

    • Table Company Profile and Development Status of Cardinal Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardinal Health

    • Figure Sales and Growth Rate Analysis of Cardinal Health

    • Figure Revenue and Market Share Analysis of Cardinal Health

    • Table Product and Service Introduction of Cardinal Health

    • Table Company Profile and Development Status of The Lubrizol Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Lubrizol Corporation

    • Figure Sales and Growth Rate Analysis of The Lubrizol Corporation

    • Figure Revenue and Market Share Analysis of The Lubrizol Corporation

    • Table Product and Service Introduction of The Lubrizol Corporation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US